title: Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively.
abstract: Pharmacological activation of histamine H3 receptors is known to reduce the release of inflammatory peptides, thereby reducing pain and inflammation, but the site(s) and mechanism(s) of these effects are currently unknown. The present study addressed these questions by examining the effects of the H3 agonist immepip and the H3 antagonist thioperamide on nociceptive behaviors and swelling produced during the rat formalin test. Systemic administration of immepip (5 and 30 mg/kg, s.c.) significantly attenuated formalin-induced flinching but not licking responses during both phases. This attenuation was reversed by either systemic (15 mg/kg, i.p.) or intrathecal (20 or 50 microg) administration of thioperamide. Furthermore, immepip (30 mg/kg, s.c.) significantly inhibited formalin-induced swelling, an action which was completely reversed by systemic (15 mg/kg, i.p.), but not intrathecal (50 microg) thioperamide. Also consistent with this pattern, intrathecal immepip (50 microg) reduced flinching responses, but had no effect on formalin-induced paw swelling. The present findings suggest that activation of H3 receptors located on peripheral and spinal terminals of deep dermal fibers attenuates formalin-induced swelling and flinching, respectively. Pharmacological stimulation of H3 receptors could be an important therapeutic approach for many disorders related to deep dermal or inflammatory pain.
authors: Center for Neuropharmacology and Neuroscience, Albany Medical College MC-136, Albany, NY 12206, USA.
authors: Keri E
authors: KE
authors: Cannon
authors: Rob
authors: R
authors: Leurs
authors: Lindsay B
authors: LB
authors: Hough
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control; D005557:Formaldehyde; D017442:Histamine Agonists / Q000494:pharmacology*; D006633:Histamine Antagonists / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology*; D007249:Inflammation / Q000139:chemically induced* / Q000517:prevention & control*; D007278:Injections, Spinal; D008297:Male; D009411:Nerve Endings / Q000187:drug effects; D009412:Nerve Fibers / Q000187:drug effects; D009475:Neurons, Afferent / Q000187:drug effects; D010147:Pain Measurement / Q000187:drug effects*; D017933:Peripheral Nervous System / Q000187:drug effects / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018100:Receptors, Histamine H3 / Q000187:drug effects*; D012867:Skin / Q000294:innervation; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism*
chemical_list: D017442:Histamine Agonists; D006633:Histamine Antagonists; D007093:Imidazoles; D010880:Piperidines; D018100:Receptors, Histamine H3; C085755:4-(1H-imidazol-4-ylmethyl)piperidine; D005557:Formaldehyde; C052075:thioperamide
references: Eur J Pharmacol. 2000 Mar 10;391(1-2):81-9
references: 10720638
references: J Med Chem. 1994 Feb 4;37(3):332-3
references: 8308858
references: Neuroscience. 2001;102(4):937-44
references: 11182255
references: Prog Neurobiol. 2001 Apr;63(6):637-72
references: 11164999
references: Mech Dev. 2001 Jul;105(1-2):167-73
references: 11429293
references: J Neurosci. 2001 Sep 15;21(18):7236-46
references: 11549734
references: Neuropharmacology. 2001 Dec;41(8):928-34
references: 11747897
references: Eur J Pharmacol. 1995 Jan 24;273(1-2):83-8
references: 7537682
references: J Neurosci. 1995 May;15(5 Pt 1):3328-41
references: 7751913
references: Br J Pharmacol. 1995 Apr;114(7):1518-22
references: 7606356
references: Eur J Pharmacol. 1995 Apr 24;277(2-3):243-50
references: 7493615
references: Circ Res. 1996 May;78(5):863-9
references: 8620607
references: Neurosci Lett. 1996 Apr 12;208(1):45-8
references: 8731171
references: Eur J Pharmacol. 1995 Dec 12;287(2):127-33
references: 8749026
references: Br J Pharmacol. 1996 Dec;119(8):1656-64
references: 8982515
references: Brain Res. 1997 Apr 25;755(1):9-16
references: 9163536
references: J Pharmacol Exp Ther. 1997 Jun;281(3):1085-94
references: 9190840
references: Neuroscience. 1997 Sep;80(1):241-9
references: 9252235
references: Pharmacol Rev. 1997 Sep;49(3):253-78
references: 9311023
references: J Comp Neurol. 1997 Dec 29;389(4):545-68
references: 9421138
references: Neuroscience. 1998 Jan;82(1):223-40
references: 9483516
references: Eur J Pharmacol. 1998 Dec 4;362(2-3):149-55
references: 9874165
references: Prog Neurobiol. 1999 Jan;57(1):1-164
references: 9987804
references: Z Rheumatol. 1998;57 Suppl 2:8-13
references: 10025074
references: Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):24-34
references: 10095074
references: Brain Res Bull. 1999 Jan 15;48(2):129-41
references: 10230704
references: Eur J Pharmacol. 1999 Apr 23;371(1):23-30
references: 10355590
references: J Pain. 2005 Mar;6(3):193-200
references: 15772913
references: Mol Interv. 2006 Apr;6(2):77-88, 59
references: 16565470
references: Eur J Pharmacol. 2006 Jul 10;541(1-2):53-6
references: 16762339
references: Pain. 2007 May;129(1-2):76-92
references: 17134835
references: Prog Neurobiol. 2002 Apr;66(6):355-474
references: 12034378
references: Neuroscience. 2002;114(1):173-93
references: 12207964
references: Pain. 2003 May;103(1-2):7-9
references: 12749953
references: Eur J Pharmacol. 2003 Jun 6;470(3):139-47
references: 12798951
references: Physiol Behav. 1976 Dec;17(6):1031-6
references: 14677603
references: Biochem Soc Trans. 1980 Feb;8(1):150-5
references: 6102933
references: Nature. 1980 Jul 10;286(5769):155-7
references: 6157098
references: Br J Pharmacol. 1980 Aug;69(4):615-23
references: 6108140
references: J Neurosci. 1983 Feb;3(2):399-406
references: 6185658
references: Neurosci Lett. 1985 Jun 12;57(2):125-30
references: 2412189
references: Brain Res. 1987 Jun 23;414(1):143-8
references: 2441798
references: J Physiol. 1987 Oct;391:141-67
references: 2451003
references: Prog Brain Res. 1988;77:313-20
references: 3064174
references: Brain Res. 1989 Jul 3;491(1):93-101
references: 2788478
references: Neuroscience. 1989;31(3):807-15
references: 2480554
references: J Pharmacol Exp Ther. 1990 Mar;252(3):1261-8
references: 1690801
references: Neuroscience. 1991;43(1):197-209
references: 1717884
references: Pain. 1992 Oct;51(1):5-17
references: 1454405
references: Neuroscience. 1993 Jan;52(1):169-89
references: 8381924
references: J Neurosci. 1993 Jun;13(6):2273-86
references: 8501507
references: Anesthesiology. 1993 Aug;79(2):270-81
references: 8102041
references: J Pharmacol Exp Ther. 2000 Oct;295(1):219-25
references: 10991982